<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is particularly common in geriatric practice </plain></SENT>
<SENT sid="1" pm="."><plain>As few data are available in very elderly patients, we conducted a 54-month retrospective study in patients over 70 years with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> diagnosed at HÃ´pital Charles Foix </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with cobalamine, <z:chebi fb="3" ids="37445">folate</z:chebi> or <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> were excluded </plain></SENT>
<SENT sid="3" pm="."><plain>Regarding biological and morphologic approaches, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were classified according to the FAB criteria </plain></SENT>
<SENT sid="4" pm="."><plain>We then tempted to reclassify the patients according to the WHO criteria </plain></SENT>
<SENT sid="5" pm="."><plain>The Bournemouth scoring system was used as a prognostic tool </plain></SENT>
<SENT sid="6" pm="."><plain>During the study period, 100 patients were included, 29 males and 71 females, median age 86 +/- 7 years (70-103) </plain></SENT>
<SENT sid="7" pm="."><plain>At the time of bone marrow sampling, a peripheral blood cytopenia was documented in 64 patients, a bicytopenia in 27 patients and a <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> in 9 patients </plain></SENT>
<SENT sid="8" pm="."><plain>Isolated <z:hpo ids='HP_0001903'>anaemia</z:hpo> (Hb &lt; 12 g/dL) was found in 60 patients and isolated <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (&lt; 150 x 10(9)/L) in 4 </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0000248'>Macrocytosis</z:mp> (MCV &gt; 100 fL) was observed in 21 % of the cases </plain></SENT>
<SENT sid="10" pm="."><plain>According to the FAB criteria, the 100 patients were classified as follows: refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA): 79%; RA with ringed sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>): 8%; RA with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>): 8%; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation: 1%; <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath>: 4% </plain></SENT>
<SENT sid="11" pm="."><plain>According to the WHO classification, the patients were reclassified as follows: RA (unilineage) (with or without ringed sideroblasts): 10%; refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> with or without ringed sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>): 73%; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>: 7% (<z:e sem="disease" ids="C1318550" disease_type="Neoplastic Process" abbrv="">RAEB-1</z:e> 6%, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-21%); <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:hpo ids='HP_0005547'>Myeloproliferative disorder</z:hpo>: 4%; unclassified (hypocellularity): 5%; <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath>: 1% </plain></SENT>
<SENT sid="12" pm="."><plain>In order to estimate prognosis at the time of the bone marrow aspirate, we calculated the Bournemouth'score: 8 patients scored 0,57 scored 1,25 scored 2,8 scored 3 and 2 scored 4 </plain></SENT>
<SENT sid="13" pm="."><plain>In this geriatric population, 83% cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are RA or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e> (with or without sideroblasts); <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with excess of blasts are uncommon </plain></SENT>
<SENT sid="14" pm="."><plain>Thus, elderly patients under study with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> were diagnosed at an earlier stage of the disease than younger ones from series published in the literature </plain></SENT>
<SENT sid="15" pm="."><plain>Due to frequent comorbidities, geriatric patients may be symptomatic for a slight decrease of <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> level </plain></SENT>
<SENT sid="16" pm="."><plain>Therefore, elderly patients are investigated as soon as they present with moderate <z:hpo ids='HP_0001903'>anaemia</z:hpo> that may explain the early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> diagnosis </plain></SENT>
</text></document>